Literature DB >> 31679147

Osteosarcopenia among postmenopausal women and handgrip strength as a practical method for predicting the risk.

Buliana Hamad1, Sibel Basaran2, Ilke Coskun Benlidayi1.   

Abstract

BACKGROUND: Osteosarcopenia is a recently described geriatric syndrome. Studies concerning its role on physical function are relatively few. AIM: To evaluate the prevalence of osteosarcopenia and to analyze its relationship with physical function among postmenopausal women.
METHODS: Demographic and clinical data, fracture risk, and osteosarcopenia risk factors of 140 postmenopausal women were evaluated between April 2018 and September 2018. Body composition and bone mineral density were measured by dual-energy X-ray absorbtiometry. Handgrip strength and physical performance test results were recorded. Sarcopenia was diagnosed according to the European Working Group on Sarcopenia in Older People, whereas osteopenia/osteoporosis was diagnosed according to the World Health Organisation criteria.
RESULTS: The mean age of the patients was 64.1 ± 8.9 years. Among the patients, 64.3% (n = 90) were found to be osteosarcopenic. Insufficient protein and calcium intake and low physical activity level were found to be the most frequent risk factors. When further analysis was done according to the osteosarcopenia, sarcopenia-only, and osteoporosis-only groups, osteosarcopenia group revealed the lowest body mass index, skeletal mass index, handgrip strength values, and physical performance test results. The handgrip strength was found to be a determinant of osteosarcopenia and each 1-unit decrease in handgrip strength increased the risk of osteosarcopenia by 1.162 times (95% CI 1.086-1.25).
CONCLUSIONS: The prevalence of osteosarcopenia is high among postmenopausal women. It is recommended to be aware of osteosarcopenia while managing osteoporotic patients, to use handgrip strength as a simple screening method, and to consider sarcopenia treatment as an important component of osteoporosis prevention and treatment.

Entities:  

Keywords:  Handgrip strength; Osteopenia; Osteoporosis; Osteosarcopenia; Postmenopausal; Sarcopenia

Mesh:

Year:  2019        PMID: 31679147     DOI: 10.1007/s40520-019-01399-w

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  6 in total

1.  The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study.

Authors:  Tülay Tiftik; Murat Kara; Esra Gizem Koyuncu; Bayram Kaymak; Ömer Faruk Çelik; İrem Çiftçi; Gizem Olgu Korkmaz; Pelin Analay; Mahmud Fazıl Aksakal; Hasan Ocak; Cevriye Mülkoğlu; Hakan Genç; Ayşen Akıncı; Levent Özçakar
Journal:  Osteoporos Int       Date:  2022-10-04       Impact factor: 5.071

Review 2.  Osteosarcopenia: A Narrative Review on Clinical Studies.

Authors:  Angela Polito; Lorenzo Barnaba; Donatella Ciarapica; Elena Azzini
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 3.  Drug discovery of sclerostin inhibitors.

Authors:  Sifan Yu; Dijie Li; Ning Zhang; Shuaijian Ni; Meiheng Sun; Luyao Wang; Huan Xiao; Dingdong Liu; Jin Liu; Yuanyuan Yu; Zongkang Zhang; Samuel Tin Yui Yeung; Shu Zhang; Aiping Lu; Zhenlin Zhang; Baoting Zhang; Ge Zhang
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

Review 4.  Energy Metabolism Changes and Dysregulated Lipid Metabolism in Postmenopausal Women.

Authors:  Seong-Hee Ko; YunJae Jung
Journal:  Nutrients       Date:  2021-12-20       Impact factor: 5.717

5.  Association of total lifetime breastfeeding duration with midlife handgrip strength: findings from Project Viva.

Authors:  Irasema C Paster; Pi-I D Lin; Sheryl L Rifas-Shiman; Wei Perng; Jorge E Chavarro; Emily Oken
Journal:  BMC Womens Health       Date:  2022-07-23       Impact factor: 2.742

6.  Correlations between the Quality of Life Domains and Clinical Variables in Sarcopenic Osteoporotic Postmenopausal Women.

Authors:  Mariana Cevei; Roxana Ramona Onofrei; Felicia Cioara; Dorina Stoicanescu
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.